Immune checkpoint inhibitor triggered parkinsonism in a patient with metastatic melanoma

J Dtsch Dermatol Ges. 2020 Aug;18(8):884-885. doi: 10.1111/ddg.14209.
No abstract available

Publication types

  • Letter

MeSH terms

  • Humans
  • Immune Checkpoint Inhibitors / adverse effects*
  • Immune Checkpoint Inhibitors / therapeutic use
  • Ipilimumab / therapeutic use
  • Melanoma* / drug therapy
  • Parkinsonian Disorders* / chemically induced

Substances

  • Immune Checkpoint Inhibitors
  • Ipilimumab